Tuberculosis 2012: biology, pathogenesis and intervention strategies; an update from the city of light
Files in This Item:
|Gouzy_et_al_Res_Micro_2013.pdf||3.48 MB||Adobe PDF||Download|
|Title:||Tuberculosis 2012: biology, pathogenesis and intervention strategies; an update from the city of light||Authors:||Gouzy, Alexandre
Gordon, Stephen V.
|Permanent link:||http://hdl.handle.net/10197/5249||Date:||Jan-2013||Abstract:||Tuberculosis (TB) remains one of the world's most deadly infectious diseases, with approximately 1.5 million deaths and 9 million new cases of TB in 2010. There is an urgent global need to develop new control tools, with advances necessary in our basic understanding of the pathogen, Mycobacterium tuberculosis, and translation of these findings to public health. It was in this context that the "Tuberculosis 2012: Biology, Pathogenesis, Intervention Strategies" meeting was held in the Institut Pasteur, Paris, France from 11 to 15th Sept 2012. The meeting brought together over 600 delegates from across the globe to hear updates on the latest research findings and how they are underpinning the development of novel vaccines, diagnostics, and drugs.||Type of material:||Journal Article||Publisher:||Elsevier||Copyright (published version):||2013 Elsevier||Keywords:||Mycobacteria; Tuberculosis; Virulence; Infectious diseases; Virulence; Secretion; Inhibition; Membrane; Macrophages; Identification; Infection; Vaccine; Mycobacterium tuberculosis; Heparin binding hemagglutinin||DOI:||10.1016/j.resmic.2012.12.006||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Veterinary Medicine Research Collection|
Show full item record
Page view(s) 5066
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.